Related Experiment Video
Updated: Feb 17, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
A Familial Thoracic Aortic and Arterial Aneurysm Syndrome Associated With FBN2 (Y1311C) and MYH11 (R34T) Variants: A
Akhtar Purvez1,2, Ana Mir3, Mudhasir Bashir4
1Clinical Research, Momentum Medical Research, Charlottesville, USA.
Abstract:
Heritable thoracic aortic disease (HTAD) is a group of genetic conditions that make people more likely to have problems with their thoracic aorta, such we talk about a rare family where a 64-year-old man had a stroke caused by a tear in a brain artery, which led to worsening thoracic aortic disease that needed surgery to replace his aortic valve and root, treatment for peripheral artery aneurysms, and later, a pacemaker for heart issues. Genetic testing found the same fibrillin-2 (FBN2) (Y1311C) change in the father and both of his sons, and the father and younger son also had a different change, myosin heavy chain 11 (MYH11). Screening imaging showed that both sons had mild aortic root dilation. This case highlights an uncommon familial aortopathy involving overlapping extracellular matrix and smooth muscle contractile pathways and illustrates the value of cascade genetic testing and longitudinal imaging surveillance of at-risk family members.
Related Concept Videos
Aneurysm I: Introduction
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Pedigree Analysis
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Thoracic Aorta

